MCRO: Healthy Pullback Keeps the Triangle Breakout Intact 📊 MCRO: Healthy Pullback Keeps the Triangle Breakout Intact 🚀
📈 The Pulse:
MCRO remains in a strong uptrend following its confirmed breakout from the long-term triangle pattern. The primary bullish structure continues to favor higher prices. 📈
Any short-term pullback should be viewed as a healthy
Macro Group Pharmaceutical S.A.E.
No trades
No trades
Compare with Macro Group Pharmaceutical S.A.E.
Company info
Sector
Industry
CEO
Khaled Kamel
Website
Headquarters
Sheraton
Founded
2002
IPO date
Feb 10, 2022
ISIN
EGS7D971C011
FIGI
BBG00ZVSTJ76
Identifiers
ISIN EGS7D971C011
Macro Group Pharmaceutical SAE operates as a cosmeceutical company.The firm offers a diversified products that focuses on cosmeceuticals and herbal drugs. Its products include Seta Cream, Geskan Spray, O-Pedal Hair Serum Spray, Sono Soap, Lit Up Cream, Silicar Serum, Kenara Mouthwash, Primo Plus Lotion, Bringo Lotion, Tress Hair Oil, Rego Shampoo and Scaro Gel. The company was founded by Ahmemd El Nayeb, Michael Jonas, and Patricia Knowles in 2002 and is headquartered in Sheraton, Egypt.
Macro Group Pharmaceutical (MCRO) - EGX : Overview EGX:MCRO
Multi-Timeframe Analysis: Symmetrical Triangle Breakout & Re-test
Macro Group Pharmaceutical (MCRO) is currently trading at 1.33 EGP, exhibiting a multi-timeframe structural breakout from a high-tight symmetrical consolidation pattern following its parabolic move in late 2025.
MCRO: Breakout Confirmed as Buyers Take Control 📈 MCRO: Breakout Confirmed as Buyers Take Control 🚀
The Fundamentals 💊
Macro Group Pharmaceuticals continues to execute a strong operational turnaround, returning to profitability after previous losses. 📈
Its focus on OTC healthcare and cosmeceutical products provides higher pricing flexibility tha
MACRO — Trend Continuation Setup
Trade Plan
* Buy #1: 1.28
* Buy #2: 1.24
* Stop Loss: 1.20
Profit Management
* Target 1: 1.36
* Target 2: Trail Stop
Technical Context
The stock appears to be completing a corrective phase and may be preparing for a new impulsive advance.
**Reasons for Entry:**
* Falling Wedge reversal pa
MCRO – Triangle Coiling Under the 1.37 Trigger MCRO – Triangle Coiling Under the 1.37 Trigger 📉🧴
The Reality: I see a "Cosmeceutical Fortress" staging a strong comeback! 🌟
Macro Group completely avoids the severe raw-material traps hitting traditional industrial drug makers because its high-margin consumer skincare portfolio acts as an elite s
MCRO saw strong liquidity flow into the stock. 🚀 MCRO saw strong liquidity flow into the stock.
For me, take-profit levels have been reached ✅.
If you’re looking for an entry, wait for a trendline retest ⏳ and avoid buying above 1.15 ⚠️. ATH target remains 1.42 🎯📈
This is general information only and not financial advice. For personal guidanc
Macro Group Egypt is expected to target 2.70 then 2.92Daily chart,
the stock EGX:MCRO price is drawing a rising channel pattern.
I expect the price will break out the resistance line R1; to target the line R2, then the line R3 at around 2.92
Some intermediate resistance levels are shown on the chart.
A new entry (buy) should be made after closing
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of MCRO is 1.51 EGP — it hasn't changed in the past 24 hours. Watch Macro Group Pharmaceutical S.A.E. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange Macro Group Pharmaceutical S.A.E. stocks are traded under the ticker MCRO.
MCRO stock has fallen by −6.75% compared to the previous week, the month change is a 14.29% rise, over the last year Macro Group Pharmaceutical S.A.E. has showed a 222.01% increase.
We've gathered analysts' opinions on Macro Group Pharmaceutical S.A.E. future price: according to them, MCRO price has a max estimate of 1.57 EGP and a min estimate of 1.57 EGP. Watch MCRO chart and read a more detailed Macro Group Pharmaceutical S.A.E. stock forecast: see what analysts think of Macro Group Pharmaceutical S.A.E. and suggest that you do with its stocks.
MCRO reached its all-time high on Aug 11, 2026 with the price of 1.74 EGP, and its all-time low was 0.34 EGP and was reached on Aug 5, 2024. View more price dynamics on MCRO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MCRO stock is 2.67% volatile and has beta coefficient of 0.18. Track Macro Group Pharmaceutical S.A.E. stock price on the chart and check out the list of the most volatile stocks — is Macro Group Pharmaceutical S.A.E. there?
Today Macro Group Pharmaceutical S.A.E. has the market capitalization of 5.20 B, it has increased by 4.79% over the last week.
Yes, you can track Macro Group Pharmaceutical S.A.E. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MCRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Macro Group Pharmaceutical S.A.E. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Macro Group Pharmaceutical S.A.E. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Macro Group Pharmaceutical S.A.E. stock shows the buy signal. See more of Macro Group Pharmaceutical S.A.E. technicals for a more comprehensive analysis.









